A Phase II Study of ZD1839 (Iressa) [gefitinib] Plus Anastrozole (Arimidex) in Patients With Relapsed Ovarian Cancer
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2012
At a glance
- Drugs Anastrozole (Primary) ; Gefitinib (Primary)
- Indications Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 02 Jan 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 29 Oct 2005 New trial record.